Adaptive Biotechnologies
ADPT
ADPT
206 hedge funds and large institutions have $5.41B invested in Adaptive Biotechnologies in 2020 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 96 increasing their positions, 43 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
11% more capital invested
Capital invested by funds: $4.89B → $5.41B (+$523M)
5% more funds holding
Funds holding: 196 → 206 (+10)
2.4% more ownership
Funds ownership: 79.63% → 82.03% (+2.4%)
Holders
206
Holding in Top 10
6
Calls
$20.2M
Puts
$5.3M
Top Buyers
| 1 | +$69.3M | |
| 2 | +$54.3M | |
| 3 | +$41.8M | |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$34.7M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$29.3M |
Top Sellers
| 1 | -$97.3M | |
| 2 | -$16.7M | |
| 3 | -$15.5M | |
| 4 |
BlackRock
New York
|
-$14.8M |
| 5 |
RSWM
Robertson Stephens Wealth Management
San Francisco,
California
|
-$10.2M |